Clinical characteristics and risk stratification of desmoplakin cardiomyopathy

Weijia Wang1,2, Brittney Murray1, Crystal Tichnell1

  • 1Division of Cardiology, Department of Medicine, Johns Hopkins University, Johns Hopkins Hospital, Blalock 545, 600 North Wolfe Street, Baltimore, MD 21287, USA.

Insights

Desmoplakin (DSP) cardiomyopathy impacts both heart ventricles, posing a high risk for ventricular arrhythmias and heart failure. Myocardial injury is linked to poorer outcomes, highlighting the need for improved diagnosis and risk assessment in DSP cardiomyopathy.

Area of Science:

  • Cardiology
  • Genetics
  • Molecular Biology

Background:

  • Desmoplakin (DSP) cardiomyopathy is an emerging cause of arrhythmogenic cardiomyopathy.
  • Genetic variants in DSP are increasingly recognized as a cause of inherited heart disease.

Purpose of the Study:

  • To characterize the diagnosis, natural history, and risk of ventricular arrhythmia and heart failure in DSP cardiomyopathy using a genotype-specific approach.
  • To evaluate the prognostic value of clinical factors and diagnostic criteria in DSP cardiomyopathy.

Main Methods:

  • Followed 91 individuals with pathogenic DSP variants for a median of 4.3 years.
  • Assessed ventricular involvement (left, right, or biventricular predominance).
  • Analyzed incidence rates of sustained ventricular arrhythmia and heart failure, and their association with clinical factors like myocardial injury and ventricular dysfunction.

Main Results:

  • Left ventricular predominance was most common (28%).
  • Myocardial injury occurred in 22% and was associated with increased risk of ventricular arrhythmia and heart failure.
  • Low left ventricular ejection fraction (<35%) and right ventricular dysfunction predicted ventricular arrhythmia, while proband status and myocardial injury predicted heart failure.
  • The arrhythmogenic right ventricular cardiomyopathy Task Force Criteria had limited sensitivity (73%) for diagnosing left-dominant disease.

Conclusions:

  • DSP cardiomyopathy affects both ventricles and carries a significant risk of ventricular arrhythmia and heart failure.
  • Myocardial injury is associated with worse disease outcomes in DSP cardiomyopathy.
  • Current diagnostic and risk stratification methods for DSP cardiomyopathy require refinement, particularly for left-dominant disease.
Abstract

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
137
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
100
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
86
Desmosomes01:05

Desmosomes

The term desmosome derives from the Greek words "desmo" and "soma" meaning "adhesion bodies." This structure was first observed during the late 1800s and described as small, dense nodules in the epidermis. Desmosomes are button-like structures that help form an interlinked network of intermediate filaments across the cells. These junctions are  essential to hold cells together under mechanical stress and to maintain tissue integrity. Desmosomes are multi-protein...
6.2K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
129
Cytoskeletal Linker Proteins - Plakins01:09

Cytoskeletal Linker Proteins - Plakins

Plakins are large proteins with binding domains for microtubules, microfilaments, intermediate filaments, and membrane-associated protein complexes at cell junctions. Plakin functions are evolutionarily conserved and are primarily involved in organizing the different components of the cytoskeleton by crosslinking them to each other and connecting them to the cell-matrix and cell adhesion complexes. They are also known to interact with signal transducers, serve as scaffolds for signaling...
2.5K